Glucose-Dependent FOXM1 Promotes Epithelial-to-Mesenchymal Transition Via Cellular Metabolism and Targeting Snail in Human Pancreatic Cancer.

OBJECTIVES Transcription factor Forkhead box protein M1 (FOXM1) plays critical roles in the progression of cancer including epithelial-to-mesenchymal transition (EMT). The aim of this study is to characterize the regulatory mechanisms of FOXM1 in EMT via pancreatic cancer metabolism. METHODS We investigated the regulation of EMT via mitochondrial respiration by FOXM1 using pancreatic cancer cell lines HPAC and PANC-1 and normal human pancreatic duct epithelial cells. RESULTS Forkhead box protein M1 and Snail were strongly expressed in HPAC and PANC-1. Epithelial-to-mesenchymal transition-modulated claudin-1 level was lower in PANC-1 than in HPAC. In both cell lines in low-glucose medium, FOXM1 and Snail were decreased and claudin-1 was increased. Knockdown of FOXM1 increased claudin-1 and decreased Snail in both cell lines. Low-glucose medium and downregulation of FOXM1 inhibited the cell migration in both cell lines. In both cell lines, mitochondrial respiration was at higher levels in low-glucose medium than in high-glucose medium. Downregulation of FOXM1 induced mitochondrial respiration in high-glucose medium. In normal human pancreatic duct epithelial cells, FOXM1 and Snail were low and claudin-1 was highly expressed, whereas overexpression of FOXM1 decreased claudin-1. CONCLUSIONS Glucose-dependent FOXM1 promoted EMT via Snail and pancreatic cancer metabolism.

[1]  Yi‐Gang Li,et al.  Foxm1 is a critical driver of TGF‐β‐induced EndMT in endothelial cells through Smad2/3 and binds to the Snail promoter , 2018, Journal of cellular physiology.

[2]  M. Martini,et al.  The role of metabolic adaptation to nutrient stress in pancreatic cancer , 2018, Cell stress.

[3]  Li Yang,et al.  Regulation of the master regulator FOXM1 in cancer , 2018, Cell Communication and Signaling.

[4]  R. Chai,et al.  FoxM1 is associated with metastasis in colorectal cancer through induction of the epithelial-mesenchymal transition , 2017, Oncology letters.

[5]  Jun Liang,et al.  FoxM1 promotes epithelial-mesenchymal transition of hepatocellular carcinoma by targeting Snai1 , 2017, Molecular medicine reports.

[6]  Y. Li,et al.  FOXM1 regulates glycolysis in hepatocellular carcinoma by transactivating glucose transporter 1 expression. , 2017, Oncology reports.

[7]  Takashi Kojima,et al.  Loss of tricellular tight junction protein LSR promotes cell invasion and migration via upregulation of TEAD1/AREG in human endometrial cancer , 2017, Scientific Reports.

[8]  W. Jiang,et al.  Metastasis to Bone in Human Cancer Is Associated with Loss of Occludin Expression. , 2016, Anticancer research.

[9]  Fandi Meng,et al.  FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma. , 2015, World journal of gastroenterology.

[10]  W. Chiu,et al.  FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells , 2014, Oncotarget.

[11]  T. Martin.  The role of tight junctions in cancer metastasis. , 2014, Seminars in cell & developmental biology.

[12]  Mei Zhao,et al.  Overexpression of FOXM1 is associated with EMT and is a predictor of poor prognosis in non-small cell lung cancer. , 2014, Oncology reports.

[13]  Lingqiang Zhang,et al.  Increased FoxM1 expression is a target for metformin in the suppression of EMT in prostate cancer. , 2014, International journal of molecular medicine.

[14]  Suyun Huang,et al.  FOXM1 Promotes the Warburg Effect and Pancreatic Cancer Progression via Transactivation of LDHA Expression , 2014, Clinical Cancer Research.

[15]  Nansheng Cheng,et al.  Down-regulation of FoxM1 leads to the inhibition of the epithelial-mesenchymal transition in gastric cancer cells. , 2014, Cancer genetics.

[16]  K. Xie,et al.  FOXM1c Promotes Pancreatic Cancer Epithelial-to-Mesenchymal Transition and Metastasis via Upregulation of Expression of the Urokinase Plasminogen Activator System , 2014, Clinical Cancer Research.

[17]  Yongjun Tan,et al.  FOXM1 promotes the epithelial to mesenchymal transition by stimulating the transcription of Slug in human breast cancer. , 2013, Cancer letters.

[18]  K. Hirata,et al.  Protein kinase Cα inhibitor protects against downregulation of claudin-1 during epithelial-mesenchymal transition of pancreatic cancer. , 2013, Carcinogenesis.

[19]  E. Lam,et al.  FOXM1: From cancer initiation to progression and treatment. , 2012, Biochimica et biophysica acta.

[20]  K. Hirata,et al.  Gastrointestinal , Hepatobiliary and Pancreatic Pathology Transcriptional Control of Tight Junction Proteins via a Protein Kinase C Signal Pathway in Human Telomerase Reverse Transcriptase-Transfected Human Pancreatic Duct Epithelial Cells , 2010 .

[21]  W. Jiang,et al.  Loss of tight junction barrier function and its role in cancer metastasis. , 2009, Biochimica et biophysica acta.

[22]  S. Tsukita,et al.  Tight junction-based epithelial microenvironment and cell proliferation , 2008, Oncogene.

[23]  A. Yu,et al.  Biology of claudins. , 2008, American journal of physiology. Renal physiology.

[24]  Chi V Dang,et al.  Cancer's molecular sweet tooth and the Warburg effect. , 2006, Cancer research.

[25]  Ken Garber,et al.  Energy Deregulation: Licensing Tumors to Grow , 2006, Science.

[26]  S. Tsukita,et al.  Claudins in occluding junctions of humans and flies. , 2006, Trends in cell biology.

[27]  Francesc X. Soriano,et al.  The transcription factors Slug and Snail act as repressors of Claudin-1 expression in epithelial cells. , 2006, The Biochemical journal.

[28]  Shoichiro Tsukita,et al.  Regulation of tight junctions during the epithelium-mesenchyme transition: direct repression of the gene expression of claudins/occludin by Snail , 2003, Journal of Cell Science.